References
  1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature . 2020;579(7798):265-269.
  2. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19); 2020. Available at https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html. Accessed April 29, 2020.
  3. Gorji HA, Jafari H, Heidari M, et al. Cancer patients during and after natural and man-made disasters: a systematic review. Asian Pac J Cancer Prev . 2018;19(10):2695-2700.
  4. Chemaly RF, Vigil KJ, Saad M, et al. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer . 2012;118(18):4627-33.
  5. Yanik EL, Katki HA, Silverberg MJ, et al. Leukoplakia, oral cavity cancer risk, and cancer survival in the U.S. elderly. Cancer Prev Res . 2015;8(9):867-963.
  6. Arduino PG, Bagan J, El-Naggar AK, et al. Urban legends series: oral leukoplakia. Oral Dis . 2013;19(7):642-659.
  7. Iocca O, Sollecito TP, Alawi F, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539-555.
  8. Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol . 2016;34(2):169-178.
  9. Singh AK, Gupta R, Misra A. Comorbidities in COVID-19: outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr . 2020;14(4):283-287.
  10. Giudice LW, Graff EA, Haripersad Y, et al. Chronic disease comorbidity in patients with oral leukoplakia: a matched case-controls tudy.Oral Dis . 2020.
  11. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis . 2020.
  12. Kowalski LP, Sanabria A, Ridge JA, et al. COVID-19 pandemic: effects and evidence-based recommendations for otolaryngology and head and neck surgery practice. Head Neck . 2020.
  13. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19); 2020. Available at https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-faq.html. Accessed April 29, 2020.
  14. Peng X, Xu X, Li Y, et al. Transmissin routes of 2019-nCoV and controls in dental practice. Int J Oral Sci . 2020;12(1):9.
  15. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents.Dermatology (Basel) . 2006;212 Suppl 1:119-123. doi:10.1159/000089211